NCT03361969View on ClinicalTrials.gov

Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist.

PHASE2CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

April 16, 2018

Primary Completion Date

May 15, 2020

Study Completion Date

May 15, 2020

Conditions
Prostatic Neoplasm
Interventions
DRUG

Estetrol

estetrol formulated in tablets

DRUG

Placebo Oral Tablet

placebo tablets

Trial Locations (6)

6803 AA

Andros Men's Health Institutes, Arnhem

Unknown

Noord West Ziekenhuis, Alkmaar

St Antonius Ziekenhuis, Nieuwegein

CWZ, Nijmegen

Antonius Ziekenhuis, Sneek

Isala Zwolle, Zwolle

Sponsors
All Listed Sponsors
lead

Pantarhei Oncology B.V.

OTHER

NCT03361969 - Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist. | Biotech Hunter | Biotech Hunter